pylori as a standard therapy based on amoxicillin and clarithromycin, exhibits a decreasing trend, in the range of 74.6%–75.8% in South Korea, which represents a high burden for the country of H. pylori [ 6 7 ].
← all excerpts
Can Aminoglycosides Be Used as a New Treatment for <i>Helicobacter pylori</i>? <i>In vitro</i> Activity of Recently Isolated <i>Helicobacter pylori</i>.
1
—
—